KRS Global Biotechnology, Inc. is recalling 1,141 vials of L-Asparaginase (10,000 International Units per vial), a lyophilized prescription medication for IV, IM, or SC use. This recall was initiated because the product lacks sterility assurance, meaning the vials may contain microorganisms that should not be present in an injectable drug. Consumers who have these vials should not use them and should immediately contact their veterinarian or healthcare provider, as the product is intended for veterinary use.
A lack of sterility in an injectable medication can lead to serious, potentially life-threatening infections at the site of injection or in the bloodstream. While no specific injuries have been reported, the contamination of a sterile drug product poses a significant health risk to the animals receiving it.
Product return for refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response